Ventricular myocytes isolated from hearts of streptozotocin (STZ)-diabetic rats exhibit increased spontaneous Ca 2+ release. Studies attribute this defect to an enhancement in activity of type 2 ryanodine receptor (RyR2). To date, underlying reasons for RyR2 dysregulation remain undefined. This study assesses whether the responsiveness of RyR2 following stimulation by intrinsic ligands is being altered during experimental type 1 diabetes (T1D).
Introduction
More than 12 million children, adolescents, and young adults worldwide have type 1 diabetes (T1D) mellitus, 1 a syndrome that results from loss of insulin-producing pancreatic beta cells. In the USA, about 1.2 million individuals have T1D. 2 These individuals rely on a combination of exogenous insulin, food management, and moderate exercise to regulate their blood glucose levels on a daily basis. 3 However, for a significant number of them, tittering their blood glucose (even with an insulin pump) before and after meals to physiologic levels remains challenging and the consequences of this glucose dysregulation are devastating. They develop cardiovascular diseases including heart failure at rates three to five times higher than that of the general population. 4, 5 A significant percentage of adolescents and young adults ( 6%) with T1D also succumb to sudden cardiac death as a result of ventricular arrhythmias triggered by iatrogenic insulin-induced hypoglycaemia. 6 Hypoglycaemia-induced arrhythmias can also be precipitated if the insulin dose is not lowered and/or carbohydrate intake increased prior to intense exercise training. 7 To date, mechanisms responsible for heart failure in individuals with TID remain incompletely understood. Excitation-contraction coupling is the fundamental cellular process that keeps the heart beating in a rhythmic manner. Following depolarization, L-type Ca 2+ channels on invaginated T-tubules activate, allowing the influx of a small amount of Ca 2+ into the myocyte.
This influxed Ca 2+ binds to and simultaneously activates multiple, juxtaposed type 2 ryanodine receptor (RyR2) on the sarcoplasmic reticulum (SR), elevating cytosolic-free Ca 2+ ≥10-fold and triggering contraction. Contraction is terminated when released Ca 2+ is returned to the SR via sarco(endo)plasmic reticulum Ca 2+ ATPase (SERCA2a) and the influxed Ca 2+ extruded via the sarcolemmal Na + -Ca 2+ exchanger. 8, 9 Using the streptozotocin (STZ)-induced type 1 diabetic rat model, several groups including ours have found perturbation in myocyte intracellular Ca 2+ handling including reductions in the rate of Ca 2+ release from the SR and the amplitude of evoked Ca 2+ release during T1D. 10 -14 Using confocal microscopy in the line-scan mode, we and others also discovered enhanced spontaneous Ca 2+ release in ventricular myocytes isolated from hearts of T1D rats 13 -15 and attributed it in part to an increase in the activity of RyR2. Unregulated or aberrant release of Ca 2+ from the SR is especially deleterious as it not only reduces the SR Ca 2+ content and the beat-to-beat force of cardiac contraction but can also induce delayed after depolarization (DAD) and ventricular arrhythmias. 16, 17 Initially, the 'leakiness' of RyR2 during T1D was attributed to an increase in phosphorylation at Ser2808 and dissociation of FKBP12.6 (calstabin-2) from the RyR2 complex. 13, 14 We later concluded that increased phosphorylation of RyR2 at Ser2808 and Ser2814 and/or dissociation of FKBP12.6 per se are unlikely to be principal causes for the enhanced activity of RyR2 during experimental T1D. 15 This study was designed to assess whether the responsiveness of RyR2 to intrinsic ligands is being altered during T1D, i. 13, 15, 19 Animals with blood glucose levels ,15 mmol/L were injected with a second dose of STZ (usually 22 mg/kg, i.v.). Six weeks after STZ injections, diabetic rats were randomly divided into two groups. One group was treated with insulin pellets (0.5-0.75 mm × 5 mm) inserted subcutaneously to attain the euglycemic state. The other diabetic group remained untreated.
In vivo assessment of ventricular function
M-mode echocardiography was performed at the end of the 8-week protocol in anaesthetized animals (100 mg/kg ketamine/10 mg/kg acepromazine, i.p.) as described earlier to assess left ventricular function. 13, 15, 19 Left ventricular end-diastolic diameter (LVEDD), left ventricular endsystolic diameter (LVESD), left ventricular end-diastolic volume (LVEDV), and end-systolic volume (LVESV) were measured. Percent fractional shortening (FS) and percent ejection fraction (EF) were derived (EF ¼ [(LVEDV -LVESV)/LVEDV] × 100 and FS ¼ [(LVEDD 2 LVESD)/ LVEDD] × 100).
Isolation of ventricular myocytes
Ten minutes prior to euthanasia, animals were injected with heparin (1000 U/kg, i.p.). After euthanasia, chest cavities were opened, and hearts were rapidly removed and placed in Krebs-Henseleit buffer. Hearts were cannulated and perfused retrograde in a Langendorff's apparatus with collagenase. Cells were used within 5 -6 h following isolation. 13 
Preparation of junctional SR membrane vesicles (JSRV)
SR membranes were prepared from left ventricular tissues isolated from control (C), STZ-diabetic (D), and insulin-treated animals (Ins-D) as described earlier, 13, 15, 19 except that phosphatase inhibitors were excluded from isolation buffers to promote dephosphorylation of RyR2, and 2 mM dithiothreitol (DTT) and 5 mM reduced glutathione were included to reverse-oxidized hyperreactive cysteine residues on RyR2. Fifteen hearts from each group were pooled for preparation of SR membrane vesicles. Junctional SR vesicles (JSRV) were prepared by fractionating SR membranes using discontinuous sucrose (0.6 M, 0.8 M, 1.0 M, 1.5 M) gradient centrifugation (103 745 x g av for 2 h) and vesicles at the 1.0 to 1.5 M sucrose interface were collected.
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2.7 RyR2 content and phosphorylation status at Ser2808 and Ser2814
JSRV (30 mg) from C, D, and Ins-D rat hearts were solubilized in the gel dissociation medium, electrophoresed on a 4 -15% gradient Tris-glycine polyacrylamide gel (150 V for 210 min), and transferred overnight onto polyvinylidene fluoride membrane as described earlier. 13, 15 Western blots were then conducted to assess relative levels of the RyR2 protein and phosphorylation status at Ser2808 and Ser2814. b-Actin levels served as the internal control to correct for any variations in sample loading.
Gain of function of RyR2 during type 1 diabetes
RyR2 purification and reconstitution into proteoliposomes
Proteoliposomes containing RyR2 were prepared as described previously with some modifications. 20 -22 Briefly, JSRV (1.5 mg/mL) from C, D, and
Ins-D animals were solubilized with CHAPS and fractionated by using linear sucrose gradient centrifugation. After centrifugation, aliquots were collected and evaluated for RyR2 content using polyacrylamide gel electrophoresis. Fractions containing RyR2 proteoliposomes were pooled, dialysed, quick-frozen in liquid nitrogen, and stored frozen in the vapour phase of liquid nitrogen until use. Additional details for this procedure are listed in the Supplemental method.
Single channel studies
Single channel studies were performed as described previously. 
Measurement of cADPR levels
Macgregor et al. 23 found that cADPR increases Ca 2+ spark frequency in guinea pig ventricular myocytes. Sitsapesan et al. 24 also showed that cADPR is an activator of RyR2. This prompted us to assay cADPR levels in myocytes from control and STZ-diabetic rats. For this, ventricular myocytes were pulverized in liquid nitrogen and extracted with 0.6 M perchloric acid at 48C. Perchloric acid was neutralized with 1,1,2 trichlorotrifluoroethane and tri-n-octylamine and vortexing. The aqueous phase was then separated and pH adjusted to 8.0 using 20 mM sodium phosphate. Contaminating nucleotides were removed by adding nucleotide pyrophosphatase, alkaline phosphatase, NADase, and MgCl 2 and incubating overnight at 378C. Radioimmunoassays were then used to measure cADPR levels as described earlier. 25 2. 
Statistical analyses
Differences among values from the three JSRV groups (cRyR2, dRyR2, InsRyR2) were evaluated using ANOVA employing GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA). Data shown are means + SEM. Results were considered significantly different if P , 0.05 (95% confidence interval).
Results

Establishing diabetic cardiomyopathy in vivo
General characteristics of animals used in this study are listed in Supplementary material online, Table S1 . Heart rate, FS, EF, LVEDD, LVESD, and cardiac output of STZ-diabetic animals were less than that of control animals, consistent with our prior studies 13, 15, 19 (Supplementary material online, Figure S1 and 
Relative levels and phosphorylation status of RyR2
No significant change in steady-state levels of the RyR2 protein was seen after 8 weeks of diabetes ( Figure 1A) . Excluding phosphatase inhibitors from isolation buffers resulted in similar levels of phosphorylation at Ser2808 and Ser 2814 on cRyR2, dRyR2, and InsRyR2 ( Figure 1A) . We also anticipate similar levels of phosphorylation at Ser2030, although this was not specifically assayed. Had phosphatase inhibitors been included in the isolation buffer, RyR2 from diabetic animals (dRyR2) would have shown an increase in phosphorylation at Ser2808 and Ser2814.
13,15 Figure 1B shows a typical silver-stained electrophoretogram of JSRV fractions collected following linear gradient sucrose centrifugation and electrophoresed on 4-15% polyacrylamide gels for 3 h at 150 V. Fractions 3-6 also bound significant amounts of [ 3 H]ryanodine, indicating that the purified RyR2 was functional (i.e. in tetrameric form). Fractions 3-5 were collected, dialysed, and used for all subsequent single-channel studies.
dRyR2 exhibits enhanced activity but reduced conductance
Having concluded from prior studies 13, 15 that an increase in phosphorylation of RyR2 and/or dissociation of FKBP12.6 per se are unlikely to be underlying causes for the enhanced activity of RyR2 during experimental T1D, RyR2 from control and STZ-diabetic hearts were purified to homogeneity, reconstituted into planar lipid bilayers, and their molecular characteristics were compared. When reconstituted into planar lipid bilayers and 1.0 mM Ca 2+ added to cis chamber, mean open probability (P o ) of cRyR2 was 0.21 + 0.01 at +35 mV holding potential (HP, Figure 1C , upper left panel Figure 1C , right panel, upper). dRyR2 was activated to a greater extent by 1 mM cis Ca Figure 1C , left middle panel). Dwell times in the open and closed states for dRyR2 were also significantly altered: 7.57 + 1.31 ms and 0.23 + 0.12 ms, respectively. Mean current amplitude of dRyR2 at +35 mV was 20% less than that of cRyR2 ( Figure 1C , middle right panel, 20.72 + 0.72 pA, conductance ¼ 592 + 21 pS). Treating STZ-diabetic rats with insulin blunted these changes. Current-voltage relationships for cRyR2, dRyR2, and InsRyR2 are shown in Figure 1D . Ryanodine (10 -25 mM) added to the cis chamber induced the characteristic subconductance state, confirming that the channels under study were indeed RyR2 (data not shown). At a HP of +35 mV, channels were stable for up to 1 h and responses to ligands were typically seen within 2 min after addition of the agent.
3.6 dRyR2 showed enhanced responsiveness to high nanomolar/low micromolar Ca 21 The enhanced responsiveness of dRyR2 to 1.0 mM cis Ca 2+ prompted us to compare the responsiveness of cRyR2 and dRyR2 over a wide Ca 2+ concentration. Figure 2A Gain of function of RyR2 during type 1 diabetes at +35 mV. Mean data are shown in Figure 2D . dRyR2 was activated to a greater extent by low micromolar cis Ca 2+ (0.45 -3.3mM), but its response was similar to that of cRyR2 at higher cis Ca 2+ (10 mM to 16 mM). Insulin treatment attenuated the enhanced low micromolar Ca 2+ response ( Figure 2C ).
dRyR2 exhibits enhanced responsiveness to ATP
In addition to Ca 2+ , RyR2 is also activated by ATP. 26 McNeill and colleagues 27 also found that myocytes from STZ-diabetic rats release more intracellular Ca 2+ when challenged with ATP compared with myocytes from control animals. This prompted us to assess whether the responsiveness of RyR2 to ATP is being enhanced during T1D. When the P o of dRyR2 and cRyR2 was adjusted to similar levels by adjusting cis Ca 2+ at +35 mV HP and 1 mM ATP added to the cis chamber, the P o of dRyR2 increased from 0.26 + 0.06 to 0.48 + 0.05 while that of cRyR2 increased from 0.20 + 0.02 to 0.32 + 0.04, P , 0.05, Figure 3D . Increasing ATP concentrations further to 2 and 5 mM increased the P o of dRyR2 to 0.53 + 0.03 and 0.57 + 0.03 and the P o of cRyR2 to 0.42 + 0.03 and 0.44 + 0.02, respectively (P , 0.05). The responsiveness of cRyR2 to increasing ATP was also investigated with 0.45 mM cis Ca 2+ and representative 1 s recordings are shown in Figure 3A , further emphasizing that cRyR2 was less responsive than dRyR2 to ATP stimulation. Treating T1D animals with insulin blunted the enhanced responsiveness of RyR2 to ATP ( Figure 3C ).
Myocytes cADPR content is elevated during T1D
Another intrinsic ligand that activates RyR2 is cADPR. Recently, Kim et al. 28 found elevated levels of cADPR and the enzyme that synthesizes it, ADP-ribosyl cyclase in glomeruli of STZ-diabetic mice. This prompted us to assess whether cADPR is also being elevated in rat ventricular myocytes during T1D. Ventricular myocytes from STZ-diabetic rats contained 3× more cADPR than ventricular myocytes from control animals (2.1 + 0.78 fmol/ mg protein vs. 0.57 + 0.14 fmol/mg protein P , 0.05). At this time, it remains to be determined whether the increase in myocyte cADPR reflects an increase in expression and/or activity of ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase (CD38).
Although not assayed, we anticipate the cADPR content of myocytes isolated from insulin-treated diabetic rats to be lower than that of diabetic animals.
cADPR potentiates the binding of [ 3 H]ryanodine to RyR2
A target for cADPR is the RyR2. As such, [
3 H]ryanodine binding assays were performed to assess if the increase in cADPR is of 3.10 dRyR2 exhibits enhanced responsiveness to cADP ribose Planar lipid bilayer assays were then used to assess in more detail, mechanisms underlying cADPR actions on dRyR2. At similar P o levels, dRyR2 was activated to a greater extent by 1, 2, and 10 mM cis cADPR compared with cRyR2 ( Figure 4D ). The responsiveness of cRyR2 to increasing cADPR was also investigated in the presence of 0.45 mM cis Ca 2+ and representative 1 s recordings are shown in Figure 4A emphasizing only modest enhancement in activation (P o increased from 0.14 + 0.01 to 0.22 + 0.01, 0.19 + 0.03 and 0.16 + 0.04, respectively, Figure 4A and D) . 24 Insulin treatment attenuated the enhanced responsiveness of RyR2 to cADPR ( Figure 4C ).
dRyR2 exhibits enhanced luminal Ca 21 sensitivity
The activity of RyR2 is also regulated in part by luminal [Ca 2+ ].
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Figure 5A, B and D shows that unlike cRyR2 which was only modestly activated by up to 16 mM trans (luminal) Ca 2+ , significant activation of dRyR2 began with as low as 500 mM luminal Ca 2+ and persisted with higher trans Ca 2+ . Thus, the threshold for activation of dRyR2 by luminal Ca 2+ was significantly lower than that of cRyR2. Insulin treatment attenuated the reduction in luminal Ca 2+ threshold for RyR2
( Figure 5C ).
dRyR2 exhibits reduced responsiveness to Mg 21 inactivation
An increase in activity of RyR2 could also result from the inability of intrinsic deactivators to close the channel. One such inactivator ligand is Mg 2+ . 26, 32 To compare their responses to Mg 2+ inactivation, the P o of cRyR2 and dRyR2 was adjusted to 0.9 using cis Ca 2+ : 3.3 mM for dRyR2 and 7.7 mM for cRyR2, and increasing [Mg 2+ ] were added to the cis chamber at +35 mV HP. Under these conditions, addition of 1 mM Mg 2+ to the cis chamber reduced the P o of dRyR2 from 0.90 + 0.04 to 0.78 + 0.05 and the P o of cRyR2 from 0.85 + 0.03 to 0.70 + 0.02, P . 0.05, Figure 6D . Increasing the concentrations of cis Mg 2+ further to 3 and 6 mM attenuated the P o of dRyR2 to 0.72 + 0.04 and 0.66 + 0.03, respectively ( Figure 6B and D) , while Gain of function of RyR2 during type 1 diabetes that of cRyR2 was reduced to 0.42 + 0.03 and 0.23 + 0.03, respectively (P , 0.05, Figure 6D ). The ability of Mg 2+ to inactivate cRyR2 was also assessed in 3.3 mM cis Ca 2+ and representative 1 s recordings are shown in Figure 6A and D, further emphasizing that cRyR2 was more sensitive to Mg 2+ blockade than dRyR2. Treating STZ-diabetic animals with insulin blunted the loss of responsiveness of RyR2 to Mg 2+ inactivation ( Figure 6B and D) .
Discussion
Efficient and rhythmic ventricular contractions require the orchestrated actions of a number of proteins residing on the plasma membrane and inside the myocyte. 7, 8 Untimely, activation/inactivation of any one of these proteins will reduce the efficiency of this process leading to heart failure. Of particular interest in this study is RyR2, whose activity was found to be enhanced in ventricular myocytes isolated from hearts of STZ-diabetic rats. Several signalling cues, including kinases, phosphatases, oxidant (e.g. NADPH oxidases), and anti-oxidant proteins (superoxide dismutases, catalase) to name a few, contribute to produce the net activity of RyR2 in myocytes. 33 As far as we know, no prior studies have attempted to ascertain whether the enhanced activity of RyR2 during T1D is independent of these cues. To address this, RyR2 from control and STZ-diabetic rat hearts was purified to homogeneity in buffers lacking phosphatase inhibitors (so as to achieve similar degrees of phosphorylation) but with reduced glutathione and DTT (to reduce oxidized hyperreactive cysteine residues), and their responsiveness to intrinsic ligands were compared.
The model
The extensively characterized STZ-induced T1D rat model was used in this study. 34 This model recapitulates many of the cardiac defects seen in patients with T1D including bradycardia, changes in early and late transmitral flow velocities, reduction in contraction, and long QT syndrome. 35, 36 Insulin pellets inserted subcutaneously were used to maintain blood glucose levels between 19-21 mmol during the study. 19 Heart failure is induced in .95% of animals and this provides a reproducible model to investigate mechanisms underlying abnormal myocyte Ca 2+ handling during T1D.
Altered responsiveness of RyR2 following stimulation by cytoplasmic ligands
The principal finding of the present study is that the responsiveness of dRyR2 following stimulation by activator ligands (Ca 2+ , ATP, and cADPR) is potentiated during T1D while its responsiveness to Mg 2+ inactivation is blunted. This gain of function of dRyR2 is independent of phosphorylation at Ser2808 and Ser2814 and oxidation of hyperreactive cysteine residues. Earlier, we showed that disulfide bonds formed on hyperreactive cysteines on dRyR2 could be reduced by treatment with DTT, 29 which along with reduced glutathione was present in isolation buffers. Since basal cytoplasmic Ca 2+ is elevated in rat ventricular myocytes during T1D, 15 and the threshold for the activation of RyR2 by cis (cytoplasmic) Ca 2+ is reduced, these new data provide additional mechanistic insights for the increased spontaneous Ca 2+ release seen in ventricular myocytes during T1D. These new data also suggest that by increasing the activity of RyR2, cADPR is playing a role in the pathogenesis of diabetic cardiomyopathy. Since, in our proteoliposome preparations, RyR2 used are devoid of FKBP12.6 (calstabin2), these data further emphasize that the increase in spontaneous Ca 2+ sparks seen in diabetic myocytes are likely to be via mechanisms that are independent of reduced FKBP12.6 (calstabin2). 13,14,37 -39 In this study, we found that in nanomolar Ca 2+ , dRyR2 exhibited enhanced responsiveness to cis ATP stimulation. Whether this is a compensatory mechanism in response to the low ATP production in the heart during T1D 40, 41 remains to be determined. We also found elevated levels of cADPR in ventricular myocytes during T1D and this is likely to be due in part to an increase in activity of ADP-ribosyl cyclase triggered by diabetes-induced increase in angiotensin II production. 42, 43 In addition to being present in larger quantities, cis cADPR also potentiated the activity of dRyR2 in low micromolar Ca 2+ . This enhancement was shown using both binding assays and single assays. In addition to direct cis activation, since cADPR increases accumulation of Ca 2+ inside the SR 44 and since the threshold for luminal Ca 2+ activation of RyR2 is lowered during T1D, this nucleotide may also result in activation of dRyR2 from the trans side.
Reduced conductance of RyR2 during T1D
In addition to the enhanced sensitivity to low micromolar Ca 2+ , the current amplitude (conductance) of dRyR2 was also 20% less than that of cRyR2 at +35 mV HP and persisted at +20, +40, and +60 mV HP. This decrease in dRyR2 conductance could be an underlying cause for reduction in Ca 2+ spark amplitude seen in diabetic myocytes. Treating diabetic animals with insulin for 2 weeks blunted the reduction in RyR2 current amplitude (conductance), indicating that metabolic factors may be responsible. As far as we are aware, this is the first study to show reduced conductance of RyR2 during T1D.
Reduced threshold for activation by luminal Ca 21
In addition to cytoplasmic ligands, the activity of RyR2 is also regulated by luminal Ca 2+ . 30, 31 A drop in intra-SR Ca 2+ has been proposed to 'turn off' RyR2 to facilitate reloading of the SR. In the present study, we found that the threshold for the activation of RyR2 by trans (luminal) Ca 2+ was reduced during T1D. At this time, it is not clear Figure 5 Comparison of the responsiveness of cRyR2, dRyR2, and InsRyR2 to increasing trans Ca 46 these data further emphasizes that differences between dRyR2 and cRyR2 cannot be attributed to increased phosphorylation.
Summary
In the present study, we show, for the first time, a gain of function of RyR2 is a contributing cause for the increase in spontaneous Ca 2+ sparks seen in rat ventricular myocytes during T1D. During T1D, the response of RyR2 to intrinsic cytoplasmic activators is potentiated, while the response of RyR2 to physiological inhibitors is blunted. We also found that the threshold for luminal Ca 2+ activation of RyR2 is lowered during T1D. This phenotype change is independent of phosphorylation at Ser2808, Ser2814, and oxidation of hyperreactive cysteines residues. What causes the gain of function of RyR2 during T1D is not clear at this time. The enhanced activity of RyR2 is especially deleterious as Ca 2+ release from one RyR2 could diffuse to adjacent RyR2s initiating more Ca 2+ release from the SR, and generation/propagation of Ca 2+ waves. 47 Spontaneous Ca 2+ waves can activate Ca 2+ -sensitive inward currents (I Na/Ca, I Cl Ca2+ ( ) , I NS(Ca2+) ) which can prematurely depolarize ventricular myocytes leading to DAD. 47, 48 If of sufficient magnitude, DAD will depolarize the cardiomyocyte above threshold, resulting in a single or repetitive premature heartbeat and the generation of arrhythmia. In a very recent study, Kauferstein et al. 49 found a novel V4299M mutation on cardiac RyR2 in a patient with long QT syndrome. This patient did not have any mutations in the major long QT syndrome-related genes SCN5A, KCNH2, KCNQ1, KCNE1, KCNE2, KCNI2. Could this gain of function of RyR2 be an underlying cause for the increased incidence of long QT syndrome and the stress-induced ventricular arrhythmias in patients with T1D? 5 
Limitations of the study
Caution should be used when correlating our data to in vivo settings. Our experiments using isolated hearts, ventricular myocytes, and purified RyR2 were performed at room temperature and ambient O 2 tension (20%) as opposed to physiological 378C temperature and 5% O 2 levels. The former conditions are known to affect the redox status of Ca 2+ cycling proteins and intracellular Ca 2+ handling. Earlier, we proposed two population of RyR2 in diabetic myocytes. 13, 15 In this study, only Ca 2+ -responsive dRyR2 was assessed.
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